Markets › India › NSE › SMSPHARMA

SMS Pharmaceuticals Ltd

NSE:SMSPHARMAHealthcare

₹434.65−3.52%At closeAt close · Mon 19 Oct · ≈ AED 16.79 · Market cap $442.78M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	32.4%	35.2%	24.7%	29.7%	18.5%	19.7%	—	—
Operating margin	17.4%	15.3%	4.1%	18.9%	13.2%	14.8%	14.8%	+0.0 pts
Net margin	11.1%	12.1%	−1.4%	7.0%	8.8%	11.5%	11.5%	+0.0 pts
EBITDA margin	22.2%	23.2%	11.4%	16.6%	18.6%	19.3%	—	—
Return on equity	15.2%	13.2%	−1.5%	9.3%	10.8%	13.0%	13.0%	−0.0 pts
Return on assets	7.7%	7.2%	−0.8%	4.8%	6.0%	7.5%	7.5%	+0.0 pts
Return on capital employed	15.8%	11.9%	3.4%	19.1%	12.5%	13.0%	—	—
Debt / equity	0.6×	0.6×	0.6×	0.5×	0.5×	0.5×	0.5×	−0.0%
Debt / assets	31.3%	30.6%	28.9%	27.2%	27.0%	26.8%	—	—
Interest coverage	8.7×	4.2×	1.0×	5.7×	5.6×	5.7×	—	—
Current ratio	1.6×	1.9×	1.6×	1.6×	1.7×	1.8×	1.8×	+0.0%
Quick ratio	0.9×	0.6×	0.7×	0.9×	0.8×	0.8×	—	—
Cash ratio	0.2×	0.2×	0.0×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.7×	0.6×	0.6×	0.7×	0.7×	0.7×	—	—
Inventory turnover	2.8×	1.3×	1.8×	2.1×	2.2×	2.0×	—	—
Receivables turnover	5.3×	10.6×	3.5×	3.0×	3.9×	4.1×	—	—
Dividend payout	0.0%	4.1%	−36.0%	5.1%	4.9%	3.5%	—	—